Neutroprotective Efficacy of Sodium Tanshinone B on Hippocampus Neuron in a Rat Model of Focal Cerebral Ischemia

Overview

Journal Chin J Integr Med

Date 2012 Oct 23

PMID 23086488

Citations 3

Authors

Qing Cai

Hong-Wu Wang

Sheng-Yu Hua

Jun-zhen Tan

Tao Zhou

Chun-Shen Li

Affiliations

Soon will be listed here.

Abstract

Objective: To investigate the protective effects of sodium tanshinone B (STB) on brain damage following focal ischemia-reperfusion (I/R) injury through interfering with N-methyl-D-aspartic acid receptor (NMDAR) and excitatory and inhibitory amino acids, and evaluate the potential mechanisms of the neuroprotective activity of STB.

Methods: Transient forebrain ischemia was induced by middle cerebral artery occlusion (MCAO). The rats were randomized into a sham operated group, a model group (I/R) and three STB different dose groups. Rats were pretreated with STB at the doses of 4, 8, 16 mg/kg (STB(1), STB(2), STB(3)) for 3 days before MCAO. The expression of NMDAR1 was detected by immunohistochemistry and Western blotting. The concentrations of glutamate and γ-aminobutyric acid (GABA) were analyzed using high performance liquid chromatography.

Results: STB treatment reduced neurological defect scores, cerebral infarction volume and brain water content. The levels of NMDAR1 were significantly higher in the l/R and STB(1) groups than that of the sham and the STB(3) groups (P<0.01). Optical density of NMDAR1 was significantly increased in cornu ammonis (CA)1 region of the l/R group (P<0.05). STB treatment reduced NMDAR1 optical density in the CA1 region (P<0.01). The levels of glutamate were significantly lower in the hippocampus in the STB(3) group than that of the l/R, STB(1) and STB(2) groups (P<0.01).

Conclusion: Preconditioning with STB appears to be a simple and promising strategy to reduce or even prevent cerebral l/R injury and has potential for future clinical application.

Citing Articles

Ameliorating effects of traditional Chinese medicine preparation, Chinese materia medica and active compounds on ischemia/reperfusion-induced cerebral microcirculatory disturbances and neuron damage.

Sun K, Fan J, Han J Acta Pharm Sin B. 2015; 5(1):8-24.

PMID: 26579420 PMC: 4629119. DOI: 10.1016/j.apsb.2014.11.002.

Montelukast, a cysteinyl leukotriene receptor-1 antagonist protects against hippocampal injury induced by transient global cerebral ischemia and reperfusion in rats.

Saad M, Abdelsalam R, Kenawy S, Attia A Neurochem Res. 2014; 40(1):139-50.

PMID: 25403620 DOI: 10.1007/s11064-014-1478-9.

Baicalin's Therapeutic Time Window of Neuroprotection during Transient Focal Cerebral Ischemia and Its Antioxidative Effects In Vitro and In Vivo.

Cheng F, Lu Y, Zhong X, Song W, Wang X, Sun X Evid Based Complement Alternat Med. 2013; 2013:120261.

PMID: 23878589 PMC: 3708445. DOI: 10.1155/2013/120261.

References

Choi D, Rothman S . The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. Annu Rev Neurosci. 1990; 13:171-82. DOI: 10.1146/annurev.ne.13.030190.001131. View

Bederson J, Pitts L, Germano S, Nishimura M, Davis R, Bartkowski H . Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats. Stroke. 1986; 17(6):1304-8. DOI: 10.1161/01.str.17.6.1304. View

Somogyi P, Smith A, Nunzi M, Gorio A, Takagi H, Wu J . Glutamate decarboxylase immunoreactivity in the hippocampus of the cat: distribution of immunoreactive synaptic terminals with special reference to the axon initial segment of pyramidal neurons. J Neurosci. 1983; 3(7):1450-68. PMC: 6564444. View

Takahashi K, Ouyang X, Komatsu K, Nakamura N, Hattori M, Baba A . Sodium tanshinone IIA sulfonate derived from Danshen (Salvia miltiorrhiza) attenuates hypertrophy induced by angiotensin II in cultured neonatal rat cardiac cells. Biochem Pharmacol. 2002; 64(4):745-9. DOI: 10.1016/s0006-2952(02)01250-9. View

Arundine M, Tymianski M . Molecular mechanisms of glutamate-dependent neurodegeneration in ischemia and traumatic brain injury. Cell Mol Life Sci. 2004; 61(6):657-68. PMC: 11138528. DOI: 10.1007/s00018-003-3319-x. View

Durukan A, Tatlisumak T . Acute ischemic stroke: overview of major experimental rodent models, pathophysiology, and therapy of focal cerebral ischemia. Pharmacol Biochem Behav. 2007; 87(1):179-97. DOI: 10.1016/j.pbb.2007.04.015. View

Swanson R, Morton M, Savalos R, Davidson C, Sharp F . A semiautomated method for measuring brain infarct volume. J Cereb Blood Flow Metab. 1990; 10(2):290-3. DOI: 10.1038/jcbfm.1990.47. View

Gassen M, Lamensdorf I, Armony T, Finberg J, Youdim M . Attenuation of methamphetamine induced dopaminergic neurotoxicity by flupirtine: microdialysis study on dopamine release and free radical generation. J Neural Transm (Vienna). 2003; 110(2):171-82. DOI: 10.1007/s00702-002-0784-6. View

Ploughman M, Windle V, MacLellan C, White N, Dore J, Corbett D . Brain-derived neurotrophic factor contributes to recovery of skilled reaching after focal ischemia in rats. Stroke. 2009; 40(4):1490-5. DOI: 10.1161/STROKEAHA.108.531806. View

10.

Peruche B, Krieglstein J . Mechanisms of drug actions against neuronal damage caused by ischemia--an overview. Prog Neuropsychopharmacol Biol Psychiatry. 1993; 17(1):21-70. DOI: 10.1016/0278-5846(93)90032-n. View

11.

Doble A . The role of excitotoxicity in neurodegenerative disease: implications for therapy. Pharmacol Ther. 1999; 81(3):163-221. DOI: 10.1016/s0163-7258(98)00042-4. View

12.

Rossi D, Oshima T, Attwell D . Glutamate release in severe brain ischaemia is mainly by reversed uptake. Nature. 2000; 403(6767):316-21. DOI: 10.1038/35002090. View

13.

Kunkel D, Hendrickson A, Wu J, Schwartzkroin P . Glutamic acid decarboxylase (GAD) immunocytochemistry of developing rabbit hippocampus. J Neurosci. 1986; 6(2):541-52. PMC: 6568523. View

14.

Dromerick A, Edwards D, Hahn M . Does the application of constraint-induced movement therapy during acute rehabilitation reduce arm impairment after ischemic stroke?. Stroke. 2000; 31(12):2984-8. DOI: 10.1161/01.str.31.12.2984. View

15.

Kirino T . Delayed neuronal death in the gerbil hippocampus following ischemia. Brain Res. 1982; 239(1):57-69. DOI: 10.1016/0006-8993(82)90833-2. View

16.

Kawamura S, Yasui N, Shirasawa M, Fukasawa H . Rat middle cerebral artery occlusion using an intraluminal thread technique. Acta Neurochir (Wien). 1991; 109(3-4):126-32. DOI: 10.1007/BF01403007. View

17.

Sarraf-Yazdi S, Sheng H, Miura Y, McFarlane C, Dexter F, PEARLSTEIN R . Relative neuroprotective effects of dizocilpine and isoflurane during focal cerebral ischemia in the rat. Anesth Analg. 1998; 87(1):72-8. DOI: 10.1097/00000539-199807000-00016. View

18.

Kemp J, McKernan R . NMDA receptor pathways as drug targets. Nat Neurosci. 2002; 5 Suppl:1039-42. DOI: 10.1038/nn936. View

19.

Bano D, Young K, Guerin C, Lefeuvre R, Rothwell N, Naldini L . Cleavage of the plasma membrane Na+/Ca2+ exchanger in excitotoxicity. Cell. 2005; 120(2):275-85. DOI: 10.1016/j.cell.2004.11.049. View

20.

Ikonomidou C, Turski L . Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury?. Lancet Neurol. 2003; 1(6):383-6. DOI: 10.1016/s1474-4422(02)00164-3. View